Outros

Unveiling the Dual Threat: Myocarditis in the Spectrum of Dengue Fever.

Current problems in cardiology. 2024 Jan; 49(Jan):102029. doi: 10.1016/j.cpcardiol.2023.102029. pii: S0146-2806(23)00446-2.

Updates in the Management of Dengue Shock Syndrome: A Comprehensive Review.

Cureus. 2023 Oct; 15(Oct):e46713. doi: 10.7759/cureus.46713. pii: e46713.

A Narrative Review of Maternal and Perinatal Outcomes of Dengue in Pregnancy.

Cureus. 2023 Nov; 15(Nov):e48640. doi: 10.7759/cureus.48640. pii: e48640.

Review of dengue, zika and chikungunya infections in nervous system in endemic areas.

Arquivos de neuro-psiquiatria. 2023 Dec; 81(Dec):1112-1124. doi: 10.1055/s-0043-1777104. pii: .

Neurological Complications in Dengue Among Males of the Adult Age Group.

Cureus. 2024 Jan; 16(Jan):e51586. doi: 10.7759/cureus.51586. pii: e51586.

Innovations in dengue virus detection: An overview of conventional and electrochemical biosensor approaches.

Biotechnology and applied biochemistry. 2024 Jan; doi: 10.1002/bab.2553. pii: .

Molecular mechanisms in the pathogenesis of dengue infections.

Trends in molecular medicine. 2024 Apr; doi: 10.1016/j.molmed.2024.03.006. pii: S1471-4914(24)00061-3.

Dengue virus infection and neurological manifestations: an update.

Brain : a journal of neurology. 2024 Mar; 147(Mar):830-838. doi: 10.1093/brain/awad415. pii: .

Febrile Phase Soluble Urokinase Plasminogen Activator Receptor and Olfactomedin 4 as Prognostic Biomarkers for Severe Dengue in Adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Mar; 78(Mar):788-796. doi: 10.1093/cid/ciad637. pii: .

Within-host models unravelling the dynamics of dengue reinfections.

Infectious Disease Modelling. 2024 Jun; 9(Jun):458-473. doi: 10.1016/j.idm.2024.02.004. pii: .

Role of auto-antibodies in the mechanisms of dengue pathogenesis and its progression: a comprehensive review.

Archives of microbiology. 2024 Apr; 206(Apr):214. doi: 10.1007/s00203-024-03954-0. pii: .

Th2-predominant immune response underlies the pathogenesis of Dengue.

Cytokine. 2024 May; 177(May):156562. doi: 10.1016/j.cyto.2024.156562. pii: S1043-4666(24)00065-6.

Ixchiq (VLA1553): The first FDA-approved vaccine to prevent disease caused by Chikungunya virus infection.

Virulence. 2024 Dec; 15(Dec):2301573. doi: 10.1080/21505594.2023.2301573. pii: 2301573.

Ixchiq (VLA1553): The first FDA-approved vaccine to prevent disease caused by Chikungunya virus infection.

Virulence. 2024 Dec; 15(Dec):2301573. doi: 10.1080/21505594.2023.2301573. pii: 2301573.

Within-host models unravelling the dynamics of dengue reinfections.

Infectious Disease Modelling. 2024 Jun; 9(Jun):458-473. doi: 10.1016/j.idm.2024.02.004. pii: .

Th2-predominant immune response underlies the pathogenesis of Dengue.

Cytokine. 2024 May; 177(May):156562. doi: 10.1016/j.cyto.2024.156562. pii: S1043-4666(24)00065-6.

Role of auto-antibodies in the mechanisms of dengue pathogenesis and its progression: a comprehensive review.

Archives of microbiology. 2024 Apr; 206(Apr):214. doi: 10.1007/s00203-024-03954-0. pii: .

Molecular mechanisms in the pathogenesis of dengue infections.

Trends in molecular medicine. 2024 Apr; doi: 10.1016/j.molmed.2024.03.006. pii: S1471-4914(24)00061-3.

Febrile Phase Soluble Urokinase Plasminogen Activator Receptor and Olfactomedin 4 as Prognostic Biomarkers for Severe Dengue in Adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Mar; 78(Mar):788-796. doi: 10.1093/cid/ciad637. pii: .

Dengue virus infection and neurological manifestations: an update.

Brain : a journal of neurology. 2024 Mar; 147(Mar):830-838. doi: 10.1093/brain/awad415. pii: .

Dengue.

Lancet (London, England). 2024 Feb; 403(Feb):667-682. doi: 10.1016/S0140-6736(23)02576-X. pii: S0140-6736(23)02576-X.

Innovations in dengue virus detection: An overview of conventional and electrochemical biosensor approaches.

Biotechnology and applied biochemistry. 2024 Jan; doi: 10.1002/bab.2553. pii: .

Unveiling the Dual Threat: Myocarditis in the Spectrum of Dengue Fever.

Current problems in cardiology. 2024 Jan; 49(Jan):102029. doi: 10.1016/j.cpcardiol.2023.102029. pii: S0146-2806(23)00446-2.